Oral manifestations and CD4+T lymphocyte count in HIV (+) adult patients treated at San Juan de Dios Hospital-Santiago, Chile

被引:0
作者
Donoso-Hofer, Francisca [1 ]
de la Maza Acevedo, Jaime
Cornejo Ovalle, Marco [1 ]
机构
[1] Univ Chile, Fac Odontol, Santiago, Chile
来源
REVISTA CHILENA DE INFECTOLOGIA | 2022年 / 39卷 / 04期
关键词
HIV/AIDS; T4; lymphocytes; CD4; count; oral manifestations; oral lesion oral candidiasis; oral Kaposi sarcoma; oral no; Hodgkin lymphoma; CELL COUNT; LESIONS; HIV/AIDS; PREVALENCE; SARCOMA; DISEASE; HAART;
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Oral lesions classified as strongly associated with HIV infection occur in cases of severe immunosuppression (CD4+ T lymphocyte count <= 200 cells/mm(3) of blood). Aim: To associate the presence of oral lesions strongly associated with HIV infection with CD4+ T lymphocytes count at the time of diagnosis. Methods: A cross-sectional study was carried out in PLHIV treated at the San Juan de Dios Hospital between 2013 and 2019. Oral lesions were diagnosed by the EC-Clearinghouse - OHARA criteria and immunosuppression was determined according to the CD4+ T lymphocyte count. Results: Of the 240 recruited patients, 35 had lesions strongly associated with HIV infection and 26 of them had severe immunosuppression. The probability of occurrence of a lesion strongly associated with HIV infection is 12.3 times higher in patients with severe immunosuppression. Conclusion: There is a statistically significant association between a severe immunosuppression and the presence of oral manifestations strongly associated with HIV/ AIDS infection, which has clinical relevance since it is presented as a clinical tool for initial diagnosis, disease progression and monitoring of antiretroviral therapy.
引用
收藏
页码:413 / 420
页数:8
相关论文
共 27 条
  • [1] Askinyte Daiva, 2015, Stomatologija, V17, P21
  • [2] Basavaraj K F, 2012, J Nat Sci Biol Med, V3, P189, DOI 10.4103/0976-9668.101913
  • [3] Berberi A, 2017, J KOR ASSOC ORAL MAX, V43, P388, DOI 10.5125/jkaoms.2017.43.6.388
  • [4] Predictive value of group I oral lesions for HIV infection
    Bhayat, Ahmed
    Yengopal, Veerasamy
    Rudolph, Michael
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2010, 109 (05): : 720 - 723
  • [5] Impact of highly active antiretroviral therapy on the prevalence of oral lesions in HIV-positive patients: a systematic review and meta-analysis
    de Almeida, V. L.
    Lima, I. F. P.
    Ziegelmann, P. K.
    Paranhos, L. R.
    de Matos, F. R.
    [J]. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2017, 46 (11) : 1497 - 1504
  • [6] Donoso-Hofer F., 2015, REV CHILENA INFECTOL, V33, P27, DOI [10.4067/S0716-10182016000700004, DOI 10.4067/S0716-10182016000700004]
  • [7] Eyeson JD, 2000, ORAL DIS, V6, P267, DOI 10.1111/j.1601-0825.2000.tb00137.x
  • [8] Oral Kaposi's sarcoma: a review and update
    Fatahzadeh, Mahnaz
    Schwartz, Robert A.
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2013, 52 (06) : 666 - 672
  • [9] Kaposi sarcoma: review and medical management update
    Fatahzadeh, Mahnaz
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2012, 113 (01): : 2 - 16
  • [10] Frimpong P, 2017, J KOR ASSOC ORAL MAX, V43, P29, DOI 10.5125/jkaoms.2017.43.1.29